TG 100801
TG 100801 is a proagent that generates TG 100572 by de-esterification in development to treat age-related macular degeneration. TG 100572 is a multi-targeted kinase inhibitor which inhibits receptor tyrosine kinases and Src kinases; has IC50s of 2, 7, 2, 16, 13, 5, 0.5, 6, 0.1, 0.4, 1, 0.2 for VEGFR1, VEGFR2, FGFR1, FGFR2, PDGFRβ, Fgr, Fyn, Hck, Lck, Lyn, Src, Yes, respectively.
Catalog Number | E7541 |
Molecular Formula | C20H17F2N3O3.HCl |
CAS# | 867331-82-6 |
Inchi | InChI=1S/C20H17F2N3O3.ClH/c21-12-1-3-13(4-2-12)25-11-15(20(27)28)19(26)14-9-16(22)18(10-17(14)25)24-7-5-23-6-8-24;/h1-4,9-11,23H,5-8H2,(H,27,28);1H |
Inchi Key | KNWODGJQLCISLC-UHFFFAOYSA-N |
SMILES | C1CN(CCN1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=CC=C(C=C4)F)F.Cl |
Size | 5mg |
Supplier Page | http://www.selleckchem.com/products/tg-100801.html |
Additional Information | https://file.selleck.cn/downloads/struct/e7541-tg-100801-chemical-structure-tube.png |